New Drug Application for RiVive Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA

PITTSBURGH, Dec. 26, 2022. Harm Reduction Therapeutics (HRT), Inc., a 501(c)(3) nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by making free or low-cost over-the-counter (OTC) naloxone nasal spray available to...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials